Tag: atrial fibrillation

First patient treated in TERMINATE AF clinical trial

The first patient has been treated in the TERMINATE AF trial (Medtronic). This is a multi-centre study evaluating two surgical ablation devices—the Cardioblate irrigated...

First patient treated in STELLAR US study evaluating next-generation balloon ablation...

Biosense Webster has enrolled and treated the first patient in its STELLAR US investigational device exemption (IDE) study. The study will evaluate the safety...

AHA 2018: Computerised-decision support has the potential to be a “powerful...

Data presented at the 2018 American Heart Association (AHA) scientific session scientific sessions (10–12 November, Chicago, USA) indicate that the use of alert-based computerised-decision...

New report on the burden of AF in Europe released

During AF Association Global AF Aware Week, Biosense Webster EMEA has published a report that uncovers the growing burden of atrial fibrillation (AF) on...

New harmonised outcome measures for AF published

New harmonised outcome measures for atrial fibrillation (AF) have been published in HeartRhythm. The work was funded by the Agency for Healthcare Research and...

Migraines that affect vision may increase risk of irregular heartbeat

People who experience migraine with visual aura may have an increased risk of atrial fibrillation, according to a study published in the online issue...

AI-based solution to screen atrial fibrillation to improve stroke prevention

Maisense, a start-up company specialising in stroke prevention, has recently introduced an AI-based solution that can screen stroke through early detection of atrial fibrillation...

DIAMOND-AF paroxysmal study complete with first enrolment in DIAMOND-AF II persistent...

EPIX Therapeutics, a medical device company that designs and manufactures a catheter-based system for the treatment of patients with atrial fibrillation (AF), has announced...

Cardialen Closes US$17 Million Series B Financing for implantable defibrillator

Cardialen, a medical device company developing a low-energy implantable defibrillation therapy designed to more gently restore normal heart rhythm, has announced the closing of...

Biosense Webster announces first patients enrolled in post-market approval study for...

Johnson & Johnson have announced that Biosense Webster has received approval from the US Food and Drug Administration (FDA) for its VISITAG SURPOINT External...

Patients with new-onset atrial fibrillation after TAVI have highest risk of...

Amit N Vora (Duke University Medical Center/the Duke Clinical Research Institute, Durham, USA) and others report in in JACC: Cardiovascular Interventions that patients who...

Four out of 10 patients with atrial fibrillation have unknown brain...

Four out of ten patients with atrial fibrillation but no history of stroke or transient ischaemic attack have previously unknown brain damage, according to...

CONVERGE IDE clinical trial completes enrolment

Atricure have announced that the enrolment of the full cohort of 153 patients in the CONVERGE IDE clinical trial has been completed. CONVERGE IDE is...

Boston Scientific to acquire Cryterion Medical

As part of its plan to expand it atrial fibrillation ablation therapy offering, Boston Scientific Corporation has announced a definitive agreement to acquire Cryterion...

Obese people with atrial fibrillation can reduce or reverse the effects...

Published in the heart journal Europace, the researchers found that a 10% loss in weight along with management of associated risk factors, can reverse the...

Binge drinking affects heart rhythm

A new study has found that the more alcohol you drink, the higher your heart rate gets. These finding were presented at European Heart...

More than US$28 million awarded for new atrial fibrillation research centres...

The American Heart Association has announced research grants totalling more than US$28 million to the scientific teams that will create a new research network...

Zenicor selected as supplier to the world’s largest screening programme for...

Zenicor Medical Systems AB has been selected as sole supplier for a screening programme in the UK for atrial fibrillation. The screening programme is...

Zio by iRhythm shown to improve detection of previously undiagnosed atrial...

iRhythm Technologies has announced primary results of the mHealth Screening to Prevent Strokes (mSToPS) study that evaluated detection of silent atrial fibrillation (AF) in...

CardioFocus announces initiation of HeartLight X3 clinical evaluation

CardioFocus have announced the initiation of a clinical evaluation of the new HeartLight X3 system for the treatment of AF. Building upon the advanced features of the...

Short-term DAPT is feasible for patients undergoing percutaneous LAA closure

Felix Weise (Cardioangiologisches Centrum Bethanien, Frankfurt, Germany) and others report in EuroIntervention that a strategy of six weeks’ duration of dual antiplatelet therapy (DAPT)...

New-onset atrial fibrillation after CABG significantly increases the risk of death...

New data from the EXCEL trial, which found that percutaneous coronary intervention (PCI) was non-inferior to coronary artery bypass grafting (CABG) at three years...

African Americans with atrial fibrillation at significantly higher risk of stroke

African Americans with atrial fibrillation (AF) have a significantly higher risk of stroke than Caucasians with the condition, according to new research published in HeartRhythm by...

Association found between left atrial appendage closure and readmission for thromboembolism

A collaborative study, has found that older patients with atrial fibrillation (AF) undergoing cardiac surgery accompanied with surgical left atrial appendage closure had a...

Results of CASTLE-AF trial published: catheter ablation better than conventional drug...

The results of the CASTLE-AF study, published today in the New England Journal of Medicine, show that patients treated with radiofrequency catheter ablation rather than...
imricor

Imricor announces completion of enrolment for MRI-guided ablations clinical study

Imricor Medical Systems announced today the completion of enrolment for the clinical study to evaluate Imricor’s Vision-MR Ablation Catheter for the treatment of atrial flutter...

Genetic variation “contributes substantially” to AF susceptibility

A recent study by Lu-Chen Weng (Massachusetts General Hospital, Boston, USA) et al which aimed to quantify and systematically characterise the genetic architecture of atrial...

Risk of dementia higher without oral anticoagulants for AF

A retrospective national Swedish registry study by Leif Friberg and Mårten Rosenqvist (Karolinska Institutet, Stockholm, Sweden) has found that the risk of dementia is...

Cluster analysis reveals “considerable heterogeneity” of atrial fibrillation

A cluster analysis of the data from the ORBIT-AF observational registry study has been published by Taku Inohara (Duke University Medical Center, Durham, USA)...

Apple and Stanford Medicine launch app-based arrhythmia study

Apple has launched the Apple Heart Study app, a first-of-its-kind research study using Apple Watch’s heart rate sensor to collect data on irregular heart rhythms and...
Europe AF 2017

Five surprising messages from this year’s Europe AF

1. The "ILL-CONCEIVED" pallas study may be relaunched John Camm "I want to say just a few quick words about dronedarone", John Camm (St George's University of...

Congenital heart disease in children and young adults have 22 times...

  A study published in the Circulation journal has shown that the risk of atrial fibrillation (AF) in young adults and children who suffer from...

NOAC reversal agent shows rapid and complete reversal of dabigatran

Boehringer Ingelheim has announced results from two new analyses of the phase III RE-VERSE AD study, which evaluated the safety and efficacy of idarucizumab,...
PREVAIL watchman

Vivek Reddy on the final outcomes of PREVAIL and PROTECT-AF

Boston Scientific has announced the final five-year outcomes data from the PREVAIL study during a late-breaking clinical trial session at this year’s Transcatheter Cardiovascular...

Low-risk AF for stroke identified with CHA2DS2-VASc Score

A Korean nationwide cohort study by Tae-Hoon Kim et al has shown that truly low-risk Asian patients with atrial fibrillation (AF) for stroke can...
confirm-rx

Smartphone compatible ICM launches in USA

The US Food and Drug Administration (FDA) has approved Abbott St. Jude Medical’s Confirm Rx insertable cardiac monitor (ICM), a smartphone compatible ICM designed to...

Irregular heartbeat linked to higher thyroid hormone levels

The risk of atrial fibrillation (AF) is increased in subclinical hyperthyroidism, but it has been is uncertain whether variations in thyroid function within the...

Men develop atrial fibrillation earlier than women; extra weight a factor

A study published in the American Heart Association’s journal Circulation has found that men develop atrial fibrillation (AF) about a decade earlier than women on...

Use of apixaban prior to cardioversion reduces risk of stroke

According to the results of the EMANATE trial, patients with atrial fibrillation (AF) who receive apixaban (Eliquis, Bristol-Myers Squibb/Pfizer) before undergoing elective cardioversion of...

Catheter ablation lowers mortality in atrial fibrillation patients with heart failure

Catheter ablation of atrial fibrillation significantly reduces mortality and hospitalisation in atrial fibrillation patients with heart failure in comparison with conventional treatment, data from...

Smartphone apps launched for atrial fibrillation patients and their healthcare providers

Two novel smartphone and tablet applications (apps) for atrial fibrillation patients and healthcare professionals have been launched by heart experts. The two apps will...

Left atrial appendage closure during heart surgery protects the brain from...

Closure of the left atrial appendage during open heart surgery protects the brain from infarctions and stroke, and could be routinely performed in the future,...

FDA grants marketing clearance for the Peerbridge Cor multi-channel remote ECG...

Peerbridge Health has announced that its first product, the Peerbridge Cor System—a wireless electrocardiogram (ECG) monitor—has received 510(k) clearance from the US Food and...

Significant differences among atrial fibrillation patients across Asia

The latest results from one of the largest, ongoing global disease registries in atrial fibrillation (AF)— GARFIELD-AF (global anticoagulant registry in the field-atrial fibrillation)...

ESC 2017: New research confirms significance of AliveCor’s 30-second ECG

AliveCor, the leader in FDA-cleared personal ECG technology, have announced the results of four clinical research presentations that demonstrate that AliveCor's hyper-fast, 30 second,...

ESC 2017: New subanalysis highlights benefits of edoxaban over warfarin in...

New subanalysis data demonstrate edoxaban (Lixana, Daiichi Sankyo) provide comparable efficacy and greater safety compared to warfarin, across non-valvular atrial fibrillation patients with different...

ESC 2017: Case builds for dropping aspirin from triple therapy in...

The RE-DUAL PCI trial indicates that dual therapy with the non-vitamin K antagonist oral anticoagulant dabigatran (Pradaxa, Boehringer Ingelheim)—and not aspirin—and a P2Y12 inhibitor...

EHRA Inventors Award ideas focus on cardiac remote monitoring and CRT...

For the second-year running, the European Heart Rhythm Association (EHRA) held the EHRA Inventors Award competition at EHRA-EUROPACE CARDIOSTIM (18‒21 June, Vienna, Austria), a...

Long working hours associated with higher risk of atrial fibrillation

By Angela Gonzalez People working 55 hours or more a week had an approximately 40% higher risk of atrial fibrillation compared with people working 35...

Cardiac Insight releases Cardea Solo wearable cardiac monitor for diagnosing AF...

Cardiac Insight, a US developer of wearable medical devices and diagnostic software, has announced that its US Food and Drug Administration (FDA)-approved Cardea Solo...

US FDA clears Cardiologs ECG Analysis platform

Cardiologs Technologies SAS has received US Food and Drug Administration (FDA) clearance of its ECG Analysis platform, a cloud-based cardiac monitoring-analysis web service powered...

Europace 2017: Stroke history higher in asymptomatic versus symptomatic atrial fibrillation...

Newly diagnosed asymptomatic atrial fibrillation patients have a higher rate of previous stroke than those with symptoms, according to results from the GLORIA-AF registry...

Medtronic Reactive ATP therapy slows atrial fibrillation progression in real-world population

Medtronic has announced that its Reactive atrial-based antitachycardia pacing (ATP) therapy slows the progression of atrial fibrillation (AF) in patients with implanted cardiac devices....

How safe is it to implant insertable cardiac monitors outside hospital...

Writing for Cardiac Rhythm News, Jan Steffel (Zurich, Switzerland) reviews current data and practice regarding safety of insertable cardiac monitors (ICMs) implantation in office...

HRS 2017: Watchman prevents stroke even in high-risk patients: One-year follow-up...

Left atrial appendage closure with the Watchman device (Boston Scientific) is safe and effective at stroke prevention, with a high implant and sealing success,...

Four out of 10 AF patients may not receive necessary stroke-prevention...

Many patients with an irregular heartbeat, known as atrial fibrillation, are not receiving recommended blood thinning medication they need to prevent strokes, according to...

HRS 2017: True incidence of atrial fibrillation is underestimated

A substantial number of patients at risk for atrial fibrillation (AF) may remain undetected using conventional monitoring techniques, a late-breaking clinical trial session at...

First three patients enrolled in Adagio Medical CryoCure study

The first three persistent atrial fibrillation patients have been treated using Adagio’s cryolinear ablation technology. This follows the successful treatment of over 25 arrhythmia...

Surgical left atrial appendage occlusion reduces thromboembolic stroke and mortality in...

Surgical left atrial appendage occlusion (LAAO) is associated with a reduction of thromboembolism and all-cause mortality among older atrial fibrillation (AF) patients undergoing cardiac...

Acutus Medical receives FDA clearance for AcQGuide Steerable Sheath

Acutus Medical has announced the FDA clearance of the AcQGuide Steerable Sheath, which marks the first US regulatory milestone for the company. The AcQGuide Steerable...

Survey finds 79% of atrial fibrillation patients would say “yes” to...

A new AF atrial fibrillation (AF) patient survey carried out by the AF Association has been launched. Results showed that 79% of patients surveyed—who...

Taller, heavier women have nearly threefold greater risk of atrial fibrillation

Women who are taller, heaver and have a greater body surface area have a nearly threefold greater risk of atrial fibrillation than smaller women,...

Janssen and Premier to initiate stroke risk management study among AF...

Janssen Pharmaceuticals has collaborated with Premier on the first and largest study of its kind to address an unmet medical need for hospitalised patients...

Medtronic initiates global trial of Arctic Front Advance cardiac cryoablation catheter

Medtronic has enrolled the first participants in the STOP Persistent AF clinical trial. The trial will evaluate the safety and effectiveness of a pulmonary...

First patient enrolled in Daiichi Sankyo’s ELIMINATE-AF edoxaban study

The first patient has been enrolled into Daiichi Sankyo’s ELIMINATE-AF study. The multinational, randomised phase 3b study will explore the safety and efficacy of...

ACC 2017: Uninterrupted dabigatran performs better than warfarin in atrial fibrillation...

Results from the RE-CIRCUIT study have shown that uninterrupted dabigatran (Pradaxa, Boehringer Ingelheim), was associated with fewer bleeding complications than uninterrupted warfarin before, during...

ACC 2017: Anticoagulant treatment may be unnecessary for stroke prevention following...

For patients with persistent atrial fibrillation or those who are at high risk for recurring atrial fibrillation, catheter ablation is recommended, followed most often...

AliveCor unveils first artificial intelligence-enabled platform for early atrial fibrillation detection

AliveCor has release the Kardia Pro, an industry-first artificial intelligence-enabled platform for doctors to monitor patients for the early detection of atrial fibrillation, in...

Clinical study validates efficiencies of Stereotaxis Niobe ES system compared to...

Stereotaxis has reported results of a study conducted at Centre Hospitalier Universitaire (CHU) of Saint-Étienne, France, which validates the advantages of the Niobe ES magnetic navigation...

AtriCure names US principal investigator for the CONVERGE IDE clinical trial

AtriCure has announced David B DeLurgio as the US principal investigator for the CONVERGE IDE clinical trial. DeLurgio is a cardiac electrophysiologist at Emory Healthcare in Atlanta, USA. He is...

FDA clears Reveal LINQ Insertable Cardiac Monitor with TruRhythm Detection

The US Food and Drug Administration (FDA) has given 510(k) clearance to Medtronic for its Reveal LINQ Insertable Cardiac Monitor (ICM) with TruRhythm Detection. A...

AF ablation associated with phrenic nerve injury: Is this complication now...

Phrenic nerve injury is a well-established complication of all types of atrial fibrillation (AF) ablation and is most common with balloon-based approaches, writes Hugh...

Superior vena cava does not seem to contribute to long-standing persistent...

The arrhythmogenicity of the superior vena cava has been rarely detected in patients with long-standing persistent atrial fibrillation, according to study from China recently...

SentreHEART Lariat and Eclipse receive reimbursement renewal in Germany

The German Institute for the Hospital Remuneration System (InEK) has renewed Status 1—the highest of four levels—for SentreHEART’s Lariat and Eclipse left atrial appendage...

First Texas centre uses St Jude Medical Amplatzer Amulet

The Texas Cardiac Arrhythmia Institute at St David's Medical Center,  Austin, USA became the first facility in the US state of Texas to implant...

New multidisciplinary care pathway helps to reduce the risk of recurrent...

A growing body of evidence suggests that the underlying cause for many cryptogenic strokes is atrial fibrillation (AF). However, many of these patients do...

CardioFocus HeartLight Excalibur balloon undergoes initial clinical evaluation

CardioFocus has announced the initial clinical evaluation of the HeartLight Excalibur balloon, a next-generation technology designed for the treatment of atrial fibrillation. The device...

AF Symposium 2017: First-in-man study shows promising results with a multi-electrode...

Results of AF-FICIENT, the first-in-man study which seeks to evaluate the safety and performance of the new Apama radiofrequency (RF) balloon catheter system (Apama...

AF Symposium 2017: Use of intracardiac echocardiography is a “viable option”...

Intracardiac echocardiograpy (ICE) facilitates a high success implant rate of the Amplatzer Amulet left atrial appendage (LAA) occluder (St Jude Medical/Abbott) as well as...

Case strengthens for opportunistic atrial fibrillation screening

By Angela Gonzalez In the quest to reduce the number of atrial fibrillation (AF) related strokes, which account for a third of all ischaemic strokes,...

Alcohol abuse increases risk of heart conditions as much as other...

Alcohol abuse increases the risk of atrial fibrillation, heart attack and congestive heart failure as much as other well-established risk factors such as high...

STS recommends surgical ablation as an “effective” treatment for atrial fibrillation

The Society of Thoracic Surgeons (STS) has issued new clinical guidelines that include major recommendations for the use of surgical ablation when treating atrial...

Moderate, habitual alcohol intake associated with atrial fibrillation

People who binge drink often experience an irregular heartbeat or a heart “flutter,” sometimes referred to as “holiday heart syndrome.” However, people who drink...

US FDA approves Medtronic’s Claria MRI Quad cardiac resynchronisation therapy defibrillator

Medtronic has received US Food and Drug Administration (FDA) approval for the Claria MRI Quad cardiac resynchronisation therapy defibrillator (CRT-D) SureScan device for patients...

AHA 2016: Low-dose rivaroxaban reduces clinically significant bleeding in PCI patients...

Two drug regimens involving low doses of rivaroxaban (Xarelto, Bayer)—one with a 15mg once daily dose of the drug and a P2Y12 inhibitor and...

AHA 2016: Low-dose rivaroxaban reduces clinically significant bleeding in PCI patients...

Two drug regimens involving lose doses of rivaroxaban (Xarelto, Bayer)—one with a 15mg once daily dose of the drug and a P2Y12 inhibitor and...

Patient enrolment complete in study assessing use of dabigatran atrial fibrillation...

Patient enrolment into the international Phase IIIb RE-DUAL PCI study is complete. The study is evaluating the safety and efficacy of dabigatran (Pradaxa, Boehringer...

Charity believes NHS programme will leave hundreds of atrial fibrillation patients...

Arrhythmia Alliance, the UK-based heart rhythm charity, is calling on NHS England to reconsider a programme that it says will mean the “hundreds” of...

Commissioning through evaluation for LAAO in England

Dhiraj Gupta (Liverpool Heart and Chest Hospital, Liverpool, UK) discusses NHS England's commissioning through evaluation for left atrial appendage occlusion (LAAO). This programme is...

Amulet study shows high implant success rates with Amplatzer Amulet LAA...

A study presented at the last late-breaking trial session of the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October-2 November, Washington, DC, USA) indicates...
Kardia Band

World’s smallest single-lead, medical grade ECG launched

AliveCor has announced the availability of Kardia Band—the world’s smallest single lead medical grade ECG. Kardia Band works with Apple Watch to provide a...

First patient procedure completed in UNCOVER-AF study

Acutus Medical has announced the completion of the first patient procedure in the UNCOVER-AF (Utilising novel dipole density capabilities to objectively visualise the etiology...

Lifelong high endurance exercise may cause arrhythmias

A first-of-its-kind study has found that male veteran athletes have a significantly higher prevalence of arrhythmias such as atrial fibrillation, atrial flutter, sinus pauses,...

Lifelong high endurance exercise may cause arrhythmias

A first-of-its-kind study has found that male veteran athletes have a significantly higher prevalence of arrhythmias such as atrial fibrillation, atrial flutter, sinus pauses,...

Short episodes of atrial fibrillation may not increase risk of stroke

People with pacemakers or defibrillators who experience only short episodes of atrial fibrillation have a very low risk of stroke, suggesting that anticoagulants in...

Cryoballoon ablation demonstrates lower healthcare system costs compared to radiofrequency ablation

Analyses from the FIRE AND ICE trial has shown lower costs with cryoballoon catheter ablation compared to radiofrequency ablation—related to trial period—as a result...

Heart Rhythm Congress (HRC) calls for urgent action to prevent thousands...

Heart Rhythm Congress (HRC), the UK’s largest educational congress devoted solely to heart rhythm disorders will gather over 3,000 heart rhythm experts and healthcare...

World Heart Federation launches global Roadmap to tackle atrial fibrillation

With the aim to help prevent atrial fibrillation (AF) and to improve its management worldwide— particularly in low- and middle-income countries—the World Heart Federation...

First US commercial atrial fibrillation procedure with HeartLight system performed at...

CardioFocus has announced the first commercial US procedure using its HeartLight Endoscopic Ablation system for the treatment of patients with paroxysmal atrial fibrillation (AF)...

JACC retracts OASIS trial paper

The Journal of the American College of Cardiology (JACC) has retracted the paper titled: “Impact of rotor ablation in non-paroxysmal atrial fibrillation patients: Results...

Daily alcohol consumption may lead to atrial fibrillation

Despite the common perception that moderate alcohol intake is good for the heart, new research suggests long-term alcohol consumption, even as little as one...

ESC 2016 Clinical Practice Guidelines describe benefits of cryoballoon ablation and...

Cryoballoon ablation for patients with diagnosed atrial fibrillation, and long-term cardiac monitoring for survivors of stroke who do not have an established diagnosis of atrial...

No significant differences between Watchman and Amplatzer in first comparison

Results from the first study to compare outcomes of two left atrial appendage closure devices—Watchman (Boston Scientific) and Amplatzer (St Jude Medical)—indicate that there...

St Jude Medical launches trial of Amplatzer Amulet left atrial appendage...

The St Jude Medical Amplatzer Amulet Investigational Device Exemption (IDE) trial, which will evaluate the safety and effectiveness of the company’s Amplatzer Amulet left...

ESC 2016: Edoxaban is safe and effective in AF patients undergoing...

ENSURE-AF, the largest prospective, randomised clinical trial to date of anticoagulation for electrical cardioversion in non-valvular atrial fibrillation, has shown that edoxaban is an...

Atrial fibrillation linked to wider range of serious conditions than previously...

Atrial fibrillation is associated with a wide range of serious events, including heart attacks, heart failure, chronic kidney disease, and sudden cardiac death, a...

ESC and EACTS launch first collaborative atrial fibrillation guidelines

The first European Society of Cardiology (ESC) Guidelines on Atrial Fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) have been...

Experts discuss non-responders to cardiac resynchronisation therapy at ESC scientific symposium

EPIC Alliance experts at the 2016 European Society of Cardiology (ESC; Rome, Italy) congress presented original research and real-world clinical evidence on non-responders to...

Daiichi Sankyo PREFER in AF registry suggests increased stroke risk among...

Daiichi Sankyo has announced data from new sub-analyses of the Prevention of thromboembolic events—European Registry in Atrial Fibrillation (PREFER in AF) patient registry, which...

Medtronic EffectivCRT-during atrial fibrillation algorithm can improve therapy delivery

The Cardiac Resynchronization Therapy Efficacy Enhancement (CRTee) study has shown that the Medtronic EffectivCRT-during atrial fibrillation algorithm can improve therapy delivery in heart failure...

Results of phase 3b ENSURE-AF study investigating edoxaban in AF patients...

Daiichi Sankyo has announced it will present the first results from ENSURE-AF, the largest prospective randomised clinical trial to date evaluating a non-vitamin K...

King’s College London joins with Cambridge Design Partnership to further develop...

Cambridge Design Partnership recently announced it is working with Kings College London to further develop a new steerable catheter designed to treat complex cardiac...

Bristol-Myers Squibb and Pfizer to present new apixaban analyses at ESC

Bristol-Myers Squibb and Pfizer have announced that 19 abstracts (late-breaking, rapid-fire, oral and poster presentations) on apixaban (Eliquis) will be presented at the European...

Thrombosis Research Institute to announce new real-world GARFIELD-AF registry insights in...

New analyses from the Global Anticoagulant Registry in the Field-Atrial Fibrillation (GARFIELD-AF) will be presented at the European Society of Cardiology (ESC) Congress (27‒31...

Biosense Webster announces US launch of ThermoCool SmartTouch SF catheter

Biosense Webster has announced the US launch of the ThermoCool SmartTouch SF catheter. According to a company release, the catheter pairs contact force technology...

The OASIS trial: A critical appraisal

Recent results of the first randomised trial—OASIS trial—to compare rotor-only ablation with two other ablation strategies in non-paroxysmal atrial fibrillation patients found poor outcomes...

American Academy of Neurology advises not to routinely offer percutaneous PFO...

  A practice advisory update from the American Academy of Neurology (AAN) suggests that percutaneous patent foramen ovale (PFO) closure to patients with cryptogenic ischaemic...

Sudden cardiac death is the most common cause of death in...

An analysis from the ENGAGE AF-TIMI 48 trial has found that sudden cardiac death was the single most common cause of death and accounted...

Insights into genetically-targeted prevention of atrial fibrillation in heart failure patients

The current need for new preventative therapies of atrial fibrillation in chronic heart failure patients—with fewer side effects than currently available treatment strategies—has led...

First randomised trial shows “poor outcomes” with rotor ablation

OASIS, the first randomised, controlled, multicentre clinical trial to compare rotor-only ablation with two other ablation strategies in non-paroxysmal atrial fibrillation patients found “poor...

Detection of atrial fibrillation with insertable cardiac monitors is superior to...

Results from the CRYSTAL AF trial have shown that atrial fibrillation in patients with cryptogenic stroke is better detected with insertable cardiac monitors than standard monitoring at six, 12 and 36 months.